Armata Pharmaceuticals Inc. logo

Armata Pharmaceuticals Inc.

ARMP | AMEX
Chart Builder DCF Calculator
$4.26
+$0.08 (+1.91%)
At close: Sep 21, 2026, 4:00 PM ET
$4.15
-$0.11 (-2.58%)
Pre-market: Sep 22, 2026, 5:22 AM ET

Market Data

Market Cap
$153.45M
Enterprise Value
$240.46M
Beta
1.35
Average Volume
128.92K
Shares Outstanding (Diluted)
62.04M
Shares Change YoY
71.42%
Institutional Ownership
10.75%
Exchange
AMEX
ISIN
US04216R1023

Price Performance

Price Change 1M
-14.3%
Price Change 3M
-39.2%
Price Change 6M
-50.5%
Price Change YTD
-35.1%
Price Change 1Y
41.1%
Price Change 3Y
59.0%
Price Change 5Y
17.2%
1M CAGR (ann.)
-11.1%
1Y CAGR (ann.)
41.2%
5Y CAGR (ann.)
1.3%
All-Time CAGR
-33.5%

Valuation

PE Ratio
-0.56
Forward PE
N/A
PEG Ratio
0.01
Forward PEG
0.04
PS Ratio
47.40
Forward PS
56.90
PB Ratio
-0.68
P/FCF Ratio
-6.06
P/Adj. FCF Ratio
-4.96
P/OCF Ratio
-6.17
EV/Sales
72.89
EV/EBIT
-1.41
EV/EBITDA
-1.42
EV/FCF
-9.32
Earnings Yield
-178.2%
FCF Yield
-16.5%
Adj. FCF Yield
-20.1%

Financial Health

Net Debt
$84.07M
Total Debt
$108.03M
Cash & Short-Term Investments
$23.95M
Total Assets
$89.95M
Current Ratio
0.11
Quick Ratio
0.11
Debt / Equity Ratio
-1.36
Debt / EBITDA
-0.64
Debt / FCF
-4.19
OCF / Debt
-0.24
Interest Coverage
-1.90
Altman Z-Score
-17.37
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
68.2%
Operating Profit Margin
-1233.6%
EBITDA Margin
-5121.8%
Net Profit Margin
-5825.3%
FCF Margin
-781.9%
Adj. FCF Margin
-955.3%
SBC / Revenue
173.4%
SBC Impact (per share)
-22.2%

Returns

Return on Assets
-213.7%
Return on Equity
89.7%
Return on Invested Capital
-47.4%
Return on Capital Employed
25.4%
Return on Tangible Assets
-252.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
-7.5%
Revenue CAGR 5Y
1.7%
Revenue CAGR 10Y
21.3%
EPS CAGR 3Y
-73.6%
EPS CAGR 5Y
-50.4%
EPS CAGR 10Y
47.3%
FCF CAGR 3Y
29.3%
FCF CAGR 5Y
6.7%
FCF CAGR 10Y
-14.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
4
EPS Growth Next 3Y
29.2%
Revenue Growth Next 3Y
79.3%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.57
EPS Growth Est (next Q)
-23.0%
Revenue Est (next Q)
$450K
Revenue Growth Est (next Q)
-61.2%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$15
Price Target Upside
252.1%

Cash Flow

Operating Cash Flow
$-25.42M
Free Cash Flow
$-25.79M
Adj. Free Cash Flow
$-31.51M
FCF Per Share
-$0.70
OCF Per Share
-$0.69
OCF/S Ratio
-770.5%

Income Statement

Revenue
$3.3M
Gross Profit
$2.84M
Operating Income
$-40.7M
EBITDA
$-169.56M
Net Income
$-192.18M
EPS (Diluted)
-$7.59
Revenue / Employee
$54.08K
Profit / Employee
$-3.15M
Employees
61

© 2026 bestshares.com. All rights reserved.